* Department of Environmental Sciences and Engineering, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599; Reproductive Toxicology Division, Office of Research and Development, National Health & Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711
1 To whom correspondence should be addressed at U.S. Environmental Protection Agency, ORD, National Health & Environmental Effects Research Laboratory, Reproductive Toxicology Division, MD-67, Research Triangle Park, NC 27711. Fax: (919) 541-4017. E-mail: fenton.suzanne{at}epa.gov.
Received March 22, 2005; accepted May 26, 2005
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key Words: atrazine; mammary gland; critical period; lactation.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Our previous work (Rayner et al., 2004) demonstrated that a 5-day exposure to 100 mg/kg ATR during gestation days (GD) 1519 in Long-Evans hooded rats (LE) delayed vaginal opening (VO), a sign of puberty, but did not affect estrous cyclicity or serum hormone concentrations in female offspring. This 5-day gestational exposure also delayed mammary gland (MG) growth and development in female offspring, whether or not the animals were exposed to ATR prenatally only or continued to nurse from ATR-exposed dams. However, the delayed growth and development of the MG was seen in pups as early as postnatal day (PND) 4, prior to any potential confounding hormonal effects of puberty, and were independent of pup BW (maximum decrease of 5.7% seen only in pups exposed to ATR both prenatally and potentially via nursing). The delays in development were persistent into adulthood, and were most severe in the animals that were exposed to ATR prenatally and that continued to nurse from an ATR-exposed dam.
Along with other reproductive tissues, MG development begins in utero. The mammary bud appears in mice around GD 10 or 11 (Imagawa et al., 1990), and slightly later in rats. Between GD 12 (mice) and GD 16 (rats), the bud increases in size, and the mesenchyme around the bud begins to differentiate (Hovey et al., 2002
; Knight and Sorensen, 2001
). From GD 16 to birth (mice and rats), the epithelial cells proliferate rapidly to form the beginning of the ductal tree. Also rapidly proliferating at this time is the mammary fat pad, which forms the support structure for the branching ducts (Hovey et al., 2002
; Imagawa et al., 1990
). The growth of the gland is typically isometric, growing at the same rate as the body (Borellini and Oka, 1998
), but shortly before puberty the gland undergoes allometric growth, growing at a rate two to three times faster than body growth rate (Borellini and Oka, 1998
; Hovey et al., 2002
), until terminal ducts (end structures that are a single cell layer thick and static) and lobules have formed (Daniel and Silberstein, 1987
). The functional differentiation of the gland takes place during pregnancy.
Several studies have shown that developing MG are sensitive to toxicant exposure. Fenton et al. (2002) showed that the MG of female offspring of Long-Evans dams exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) on GD 15 displayed persistently delayed development. The glands of female offspring at several developmental time points had not migrated through the fat pad, lateral branching was reduced, and terminal end-buds (rapidly dividing cells in tear-dropshaped structures) were present for extended lengths of time. Foster et al. (2004)
treated Sprague-Dawley dams with a mixture consisting of organochlorines, chlorinated benzenes, and metals at the acceptable daily intake level on GD 916, with or without postnatal genistein. Female offspring receiving both the mixture and genistein had increased female MG morphological alterations, including calcifications, epithelial hyperplasia, and cystic dilation, compared to the control and mixture groups. Bisphenol A (BPA) was shown to alter the development of CD-1 mouse MG when exposed beginning on GD 9 and continuing throughout the pregnancy (Markey et al., 2001
). Glands removed 1 month after birth from offspring of dams treated with 25 µg/kg BPA showed increased ductal elongation, whereas glands from offspring of dams treated with 250 µg/kg BPA demonstrated decreased elongation as compared to control offspring glands (possibly because of different signaling components in the low-dose effect). By 6 months of age, both groups had significantly larger ductal and alveolar structures than controls. These studies, taken together, demonstrate that MG of rats and mice can be sensitive to the effects of environmental agents during the latter half of prenatal development.
A 5-day exposure to 100 mg/kg/day ATR during GD 1519 in Long-Evans rats delayed MG growth and development in female offspring (Rayner et al., 2004). To determine if there is a critical period in which the developing mammary tissue is most sensitive to the effects of ATR, the studies presented here evaluated the effect of ATR on mammary gland development as well as traditional pubertal indicators after 3- or 7-day exposures during the latter period of gestation. The 3-day exposure periods bracket the proposed times of rat mammary bud formation, bud size increase, mesenchyme differentiation, and epithelial cell proliferation. These studies also clarified that delayed offspring mammary growth and development following in utero ATR exposure is not caused by altered serum hormones or reduced mean fetal litter weights. These persistent effects of prenatal atrazine exposure result in decreased weight gain in litters born to atrazine-exposed females.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Dosing solution and procedures.
The work reported here was conducted in two separate studies, with dosing solutions for each study described below.
Fetal weight study.
Atrazine was prepared as a suspension in 1.0% methyl cellulose in distilled water. Timed-pregnant rats were treated with 0 (vehicle), 25, 50, or 100 mg ATR/kg BW by oral gavage in a 5 ml/kg dosing volume.
Experimental design.
Vaginal opening and cyclicity.
Beginning on PND 29, female offspring (more than 24 females/group) were evaluated for vaginal opening (VO). The postnatal day of complete VO and body weight on that day were recorded. Daily vaginal smears were collected in Block 2 females beginning on PND 37 and continued until PND 67 to determine the effect of prenatal ATR exposure on early cyclicity patterns following VO. Vaginal smears were read wet on an American Optical low-power light microscope (100x) for the presence of leukocytes (metestrus/diestrus), nucleated epithelium (proestrus), or cornified epithelial cells (estrus) to determine cyclicity patterns, and day of cycle was recorded. Data were examined for 45 day normal cycles, and the number of consecutive normal cycles was recorded for each animal. Episodes of persistent diestrus or estrus were recorded, and the number of episodes per animal was compared across treatment. Animals demonstrating irregular cyclicity were defined as those not presenting at least two consecutive normal cycles between PND 37 and PND 67.
Necropsy.
Necropsies were performed following an overnight and continued stay in a quiet holding area, and by using DecapiCones for animal transfer to reduce stress.
Mammary whole mounts.
The 4th and 5th mammary glands were removed, fixed, and stained in carmine alum as a whole mount as previously described (Fenton et al., 2002) on PND 4, 22, 25, 33, 46, and 67 (24 pups/dam). Mammary glands from second generation pups were removed and stained on PND 4 and 11. Flattened whole mounts were visualized and the epithelial outgrowth was measured to the closest millimeter (mm). Length measurements for area were taken from the nipple to the farthest point of branching. However, length measurements on PND 46 were taken from the farthest branching of the 4th gland to the farthest branching of the 5th gland. Width measurements for area were taken from the two longest points of outgrowth. The whole mounts were subjectively scored (scale = 14; 1 = poor development/structure and 4 = normal development/structure for each age group; procedure available upon request) within an age group, by two individual scorers without knowledge of treatment. Mammary glands representative of the mean score of the group were photographed on a Leica WILD M420 macroscope.
Radioimmunoassay.
Sera were obtained from offspring that were decapitated on PND 33 and PND 67, and from dams at PND 11 (second generation) for use in radioimmunoassays. Serum total testosterone, androstenedione, corticosterone, and progesterone were measured using Coat-a-Count Radioimmunoassay Kits obtained from Diagnostic Products Corporation (Los Angeles, CA). Serum estrone was measured using the DSL 8700 Estrone Radioimmunoassay kit, and estradiol was measured using the 3rd Generation Estradiol Radioimmunoassay kit from Diagnostic Systems Laboratories, Inc. (Webster, TX). Serum prolactin (PRL) was analyzed by radioimmunoassay using materials supplied by the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases. All assays were run in duplicate. Stage of the estrous cycle was known at the time of necropsy and was used as a model variable in data analysis (see below).
Lactational challenge.
Dams and pups were moved to a quiet holding room on PND 10. On PND 11, dams were removed, weighed, and placed in clean individual cages with food and water ad libitum. Entire litters were weighed, and pups allowed to remain in their own nests. Two hours later, dams were placed back with their pups. The amount of time it took for dams to nest on their young was recorded, and dams were allowed to suckle their pups for 20 min, after which dams were removed and decapitated. Trunk blood was taken for serum collection. The pituitary gland was removed, weighed, and discarded. Portions of the mammary gland were removed and placed in 10% buffered formalin. Litters were reweighed immediately, and MG were removed from female pups for whole mount analysis. The uterus of dams was removed and implantation sites were counted. Male pups were euthanized.
Statistical analysis.
Dam means (pups/dam; litter as unit) were calculated for body and tissue weights, MG scores, VO day, and serum hormones. Means and adjusted means relative to body weight were calculated for organ weights. Body weights, MG scores, and serum hormone concentrations were evaluated for treatment effects within each age group by one-way analysis of variance (ANOVA, Statistical Analysis System, SAS Institute, Inc. Cary, NC). Organ weights and hormone concentrations were analyzed with respect to day of cycle by Mixed Model ANOVA, and interactions between day of cycle and group were evaluated. Analysis of covariance, with body weight as a covariate, was used to evaluate the effects of treatment on MG scores. Estrous cyclicity data were compared by Mantel-Haenszel analysis (Non-zero correlation and Row Mean Score Test). Resorption sites and pup death were analyzed in a contingency table using Fisher's exact test in Graphpad Instat (Graphpad Software, San Diego, CA). Block effects were evaluated, but none were significant. Significant treatment effects were demonstrated by p < 0.05 and specific p values are indicated throughout this manuscript.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Dam weight was recorded throughout the dosing periods, and weight gain was compared among groups (Table 1). During the GD 1315 exposure period, control dams (vehicle) gained an average of 20.4 ± 3.4 g. Dams exposed to 100 mg/kg BW/day ATR during GD 1315 and the first 3 days of GD 1319 gained no weight, significantly less than control dams, p < 0.0001. Dams dosed with ATR GD 1517 gained significantly less weight than control dams, with weight gain reduced 82%, (p < 0.0001), and ATR GD 1319 dams had a 35% reduced weight gain, (p < 0.0007) on the middle 3 days of that exposure. In the final dosing period, dams in the ATR GD 1719 group had a 90% reduction in weight gain (p < 0.0001) compared to control dams. However, those exposed to ATR GD 1319 exhibited only a 26% reduction in weight gain during the GD 1719 period, (p < 0.0403). During the entire dosing period GD 1319, control dams gained a total of 78.2 ± 6.1 g and ATR-exposed dams less than half of that amount (p < 0.0001), with most of that weight gained in the latter stages of the 7-day dose period. The dams treated with 100 mg/kg ATR gained significantly less weight than controls during all periods tested.
|
Fetal weight study.
In utero exposure during GD 1519 to 100 mg ATR/kg maternal BW lead to lower pup weight just after birth (Rayner et al., 2004) when pups also nursed from ATR-exposed dams. Atrazine-treated dams in this study exhibited significantly reduced weight gain during the exposure period when compared to vehicle-treated dams. A pronounced lack of weight gain during the dosing period in the Critical Period study described, stimulated a further study to determine if this reduction in maternal weight gain (maternal toxicity) played a role in term fetus number or fetal body weight.
Dam weight was recorded daily throughout the dosing periods, and weight gain was compared among groups. During the exposure period GD 1519, control dams gained an average of 51.2 ± 3.0 g (Table 2). Dams in the 25, 50, and 100 mg/kg ATR, groups gained 6.1%, 42.0%, and 62.9%, less weight, respectively, than control dams during the exposure period. Dams in the 50 mg/kg and 100 mg/kg groups gained significantly less weight than controls (p < 0.002), and the 25 mg/kg dose had no effect. Because the current mode of action of ATR includes altered serum prolactin, we evaluated the dam's circulating prolactin levels at GD 20 (24 h after the last dose). There were no statistically significant exposure-induced differences found in circulating prolactin levels among the groups (n > 7 dams/group; 9.38 ± 2.22 C; 6.40 ± 0.78 ATR 25 mg/kg; 8.44 ± 1.84 ATR 50 mg/kg; and 4.78 ± 0.48 ATR 100 mg/kg), although the highest ATR dose reduced serum PRL to half that in controls.
|
The body weight of female fetuses was compared among groups (Fig. 1) and no differences were found at GD 20. When female and male weights were both evaluated together, no differences were found. These data taken together suggest that, although ATR exposure during pregnancy may decrease maternal weight gain and increase the total number of reabsorbed fetuses, it had no effect on fetal weight gain, regardless of sex, over this short exposure period.
|
Vaginal opening and estrous cyclicity were evaluated as physical signs of female reproductive development (Fig. 2). Body weight at time of VO was not different among the treatment groups (panel A). Vaginal opening occurred in control animals at PND 32.6 ± 0.33 (panel B). The offspring exposed to ATR on GD 1319 displayed a significant delay in VO (34.5 ± 0.36, p < 0.0004), similar to that seen previously (Rayner et al., 2004). Vaginal opening was not significantly delayed in any other dose group (33.5 ± 0.41 GD 1315; 32.9 ± 0.31 GD 1517; and 33.2 ± 0.36 GD 1719).
|
Mammary gland development.
Mammary glands were removed from female offspring in all groups on PND 4, 22, 25, 33, 46, and 67 and examined to determine if epithelial development of the MG was affected by gestational ATR exposure. Stained epithelia were measured (area [mm2] and length [mm]) to observe differences in outgrowth into the fat pad (Table 3). Mammary gland development in female offspring was scored through whole mount analysis (Table 4, Fig. 3A).
|
|
|
Weaning occurred at either PND 22 (Block 2) or PND 25 (Block 1), and MG were taken from exposed offspring of equivalent BW. The area of the fourth gland remained significantly smaller in exposed offspring at PND 22, p < 0.03 (Table 3), with the exception of GD 1315 offspring, but the distances between the fourth and fifth glands were not different from control. The mammary glands of GD 1719 and GD 1319 offspring displayed fewer terminal end buds and lateral branches, and they had not migrated as far through the fat pad as controls (Table 4, Fig. 3B). The area of the fourth gland remained significantly smaller in ATR-exposed offspring at PND 25 (Table 3), and the distance between the glands was greater than the same distance in the control females' glands, p < 0.04. Control female offspring displayed normal mammary branching, with distended terminal end buds and terminal ducts. Glands of females in ATR-exposed groups were not as well developed. Those glands had poor migration of epithelium into the fat pad, and mammary branching was sparse in appearance with fewer lateral branches than control (Table 4, Fig. 3A).
By the peripubertal time point, PND 33, none of the ATR-exposed offspring glands were statistically smaller in area than controls (Table 3). Glands from control females displayed terminal end buds only on the most distal ends; lobules were present, and the fourth and fifth glands had grown close together (Fig. 3). Even though glands from exposed offspring were not smaller in area, the glands received lower developmental scores than controls. Atrazine-exposed glands displayed abundant terminal end buds on 23 sides of the epithelial tree, limited lobules, and sparse branching (Table 4). Figure 3A shows the distance between the fourth and fifth glands at PND 33, in addition to terminal end buds.
At early adulthood (PND 46), glands of ATR-exposed offspring were similar in length to controls (Table 3). The 4th and 5th glands had grown together by that age, and it was difficult to measure the area of each individual gland. However, whole mount analysis of the MG showed that, developmentally, ATR-exposed glands were significantly different from controls. Glands of control animals had very few terminal end buds left in the gland, and the MG was very dense with epithelial branching (Fig. 3C). Most glands of control animals resided in a resting state normally found in adult female rats. The development of mature gland structures was delayed in ATR-exposed offspring. Glands from exposed offspring were less dense and still retained many terminal end buds, with most seen in GD 1719 and GD 1319 (arrows in Fig. 3C), leading to consistently low developmental scores (Table 4). At a later point in adulthood, when all females should have been sexually mature (PND 67), ATR-exposed glands were still developmentally delayed and contained many large lobular units, with only moderate epithelial branching. Glands removed from female offspring in the GD 1719 and GD 1319 groups received epithelial development scores that were statistically equivalent over time (PND 467; Table 4). Control glands had few complex lobules and little dense branching throughout the gland, and they remained in the resting state described (not shown).
Serum hormone measurements.
To determine if ATR exposure affected circulating hormone levels, serum was separated from trunk blood of animals at PND 33 and PND 67. At PND 33, corticosterone concentrations were significantly increased in the GD 1517 group, p < 0.009; 72.1 ± 26.2, C vs. 193.9 ± 21.8, GD 1517. Although no stress events were noted, we realized that this large increase could be due to an unknown environmental stressor prior to/during necropsy. Total testosterone in GD 1319 animals was doubled compared to controls, p < 0.04; 0.203 ± 0.06, C vs 0.419 ± 0.08, GD 1319. No additional differences in hormone concentrations evaluated at PND 33 were found.
At PND 67 (Table 5), there were no consistent exposure-induced differences in hormone concentrations with respect to day of cycle, but there were some interesting trends observed when all animals were compared to control means. Estrone and its precursor androstenedione were slightly decreased in GD 1719 and GD 1319 offspring. Estradiol was slightly increased in GD 1517, GD 1719, and GD 1319 offspring, whereas its precursor testosterone was nearly doubled in GD 1319 ATR-exposed animals (similar to that seen in PND 33 animals of the same dose group). Steroid hormone ratios, particularly those controlled by aromatase and 17-ß hydroxysteroid dehydrogenase, were evaluated, but no statistical differences among the groups were detected.
|
Consequences of Brief Prenatal ATR Exposure on Second Generation
The offspring of control and ATR-treated dams were bred to control LE males (beginning PND 68) to determine if the females exposed gestationally to ATR, and exhibiting delayed MG development, would have difficulty sustaining their young. Of the 20 normal-cycling females chosen to breed (4/group), only one female in the GD 1719 group did not conceive. One female in the GD 1319 group conceived, delivered two pups, but dam and pups died before PND 4. On PND 4, individual pups in each litter (n > 3) were weighed, and the sex of each was determined. Litters were equalized to 10 pups if possible. On PND 11, dams were removed from their pups for 2 h during a lactational challenge as described.
Female pups in the groups GD 1719 and GD 1319 were significantly smaller than those of control (p < 0.003 and 0.02), with reduction in body weight of 14.8% and 12.5%, respectively. Male pups in these same groups were also smaller than control, p < 0.002 and p < 0.0001, and had body weight reduction of 15.6% and 16.7% (Fig. 4A). Mammary glands were removed from the female pups at PND 4 and scored for development and the area of the gland measured. Whole mount analysis of the fourth and fifth MG at PND 4 showed that mammary epithelial development of pups taken from GD 1719 and GD 1319 dams had few ductal buds from lateral branches and were undersized compared to glands taken from other groups. Control, GD 1315, and GD 1517 offspring glands displayed small buds on primary branches and moderate branching within the gland, and received similar developmental scores. When MG scores were compared using body weight as a cofactor, glands from GD 1719 and GD 1319 were no longer considered significantly different. The areas of the 4th mammary gland were not different among the groups. It should be mentioned that the mean body weight of pups on PND 4 in the GD 1315 and GD 1517 ATR-exposure group (male and female) were significantly greater than the control group. The development of MG in female siblings from both ATR-exposure groups was known to be similar to controls when they were mated.
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Our studies suggest that GD 1719 may be the most important period of fetal MG development, showing sensitivity to ATR that was consistent with the 7-day exposure. Our previous work showed that a 5-day in utero exposure to ATR during GD 1519 delayed MG development in the female offspring (Rayner et al., 2004). We reported that gestational exposure combined with milk consumption from an ATR-treated dam (ATR-ATR) led to more severely delayed MG development than those exposed only in utero or lactationally. In the present study, a 3-day in utero exposure, especially during GD 1719, caused MG developmental delays similar to that found in the 5-day ATR-ATR exposed animals (Rayner et al., 2004
), and the GD 1319 offspring (7-day exposed; this study), framing what we believe to be the narrowest sensitive period of MG development to non-lipophilic environmental agents to date.
It has been suggested that maternal/fetal weight gain and/or early pup weight gain might play a role in offspring reproductive tissue development, and in this case, specifically the MG. Our previous study and data presented here demonstrate that F1 offspring body weight at GD 20, PND 4, or thereafter was not a significant variable influencing MG developmental delays induced by ATR. The present fetal weight study showed that dams treated with 50 mg/kg or 100 mg/kg of ATR during GD 1519 gained significantly less weight than control dams, but was without effect on litter sizes or fetal/pup weight. During the critical period study, dams treated with 100 mg/kg BW/day ATR during the 3-day exposure period gained significantly less weight than control dams during the same time period; in fact, during early treatment periods, they gained no weight. Dams treated during GD 1319 were reduced in weight gain by almost half of control dams, but there were no differences in female offspring weight in any of the groups following birth. However, differences in F1 (specifically) MG development were apparent in groups exposed to ATR, even after 3 days. Further, as noted in Table 6, there was no significant weight difference in F1 dams used in the breeding study. Importantly, however, those same animals with delayed MG development at breeding (to generate the F2 offspring) raised pups that were significantly (from 12% to 25%) smaller than controls, suggesting that the GD 1719 and GD 1319 ATR-exposed dams were not able to produce the quality and/or quantity of milk necessary to sustain the body weight of their offspring.
Epidemiological studies concentrating on sexual maturation and growth have been conducted in populations exposed to endocrine-disrupting compounds. Pubertal development was assessed by Blanck et al. (2000) in girls exposed to polybrominated biphenyls either in utero or through breastfeeding from maternal ingestion. The exposure occurred in 1973 after accidental contamination of Michigan dairy and animal products. These investigators found that females exposed to estimated high levels (
7 parts per billion; ppb) prenatally and lactationally experienced menarche at an earlier age than females exposed to low levels who were breastfed or than females who were not breastfed. Breast development in these females was not affected by exposure. Blanck et al. (2002)
also examined the growth of these females. They found no association between height and weight and polybrominated biphenyl exposure. They did find that mothers who had higher (
5 ppb) polychlorinated biphenyl exposure had female children who weighed less than those exposed to high levels of polybrominated biphenyls. Den Hond and co-workers (2002)
assessed two suburban Belgian adolescent populations exposed to polychlorinated aromatic hydrocarbons (PCAHs) and one rural cohort. The exposure sources were industrial, and samples were taken from the adolescent participants (60% female). They found that a significant number of females in one of the polluted sites (Wilrijk) had not reached the adult stage of breast development by a mean age of 17.4 years, and that a higher serum concentration of dioxin-like compounds was associated with delayed breast development, without a change in age at menarche. These studies begin to suggest that endocrine disrupting compounds can disrupt puberty and MG development in divergent ways, not only in rodents but in the human population as well.
Although a relatively high dose of atrazine (100 mg/kg) is used in these studies, it is important to remember that each pregnant rat contains in an average of 144 developing fetal mammary buds during the time of exposure (12 buds per rat and an average of 12 pups/litter). Some dams contained as many as 204; possibly contributing to the litter-to-litter variation. This is in comparison to the two mammary buds developing in the average pregnant woman. The actual amount of ATR that reaches the developing mammary buds is the subject of on-going research in our lab.
We do not know the mode of action of ATR for the developmental delays in the rat MG. There were no changes in puberty or hormones that could be associated with delayed MG development in our study. Only the offspring from dams dosed during GD 1319 exhibited delayed VO, indicating again (also in Rayner et al. [2004]) that VO is not altered in a time/dose paradigm similar to ATR-induced MG development delays. Delayed VO seems to require longer ATR exposures than do the notable mammary changes. This situation is reminiscent of pubertal changes in U.S. girls, where the timing of breast development and menses do not necessarily go hand-in-hand. Data from over 17,000 girls (Herman-Giddens et al., 1997
) and the Third National Health and Nutrition Examination Survey (Sun et al., 2002
) demonstrated that breast and pubic hair development begin earlier in both African American and Caucasian populations and they also take longer to conclude. However, in these populations, menses occurs at an age similar to that seen 30 years ago (Chumlea et al., 2003
). Many theories exist concerning the effect of environment on changes in sexual maturity. In our study, the hormone concentrations measured from serum did not differ consistently among the groups, even when considered by stage of the estrous cycle. Statistical differences in hormone concentrations at PND 33 did not persist to PND 67 and were not outside the biologically normal value ranges. This further indicates that serum hormone levels are not a direct causal factor in delaying MG development after ATR exposure. It is entirely possible that the effect of ATR is an early effect and that the programed growth pattern of the mammary epithelium was altered by the prenatal exposures.
In an unpublished study prepared by Ciba-Geigy and accepted by the EPA (Mainiero et al., 1987), rats were exposed to ATR over two generations. Male and female rats were treated through diet with approximately 0.5, 5, and 50 mg/kg/day ATR prior to mating, and then females were further treated during gestation and lactation. The first generation of pups were weaned and treated through the diet for 12 weeks prior to mating. The only changes noted in the two sets of parents were weight reductions at the high dose, but in the offspring no treatment-related changes were noted in the reproductive parameters evaluated, including fertility, postnatal mortality, or developmental delays. Our study, over two generations, consisted of treating only F0 pregnant dams for 3 or 7 days with ATR by oral gavage. Female offspring displayed persistent delayed MG development (an endpoint not evaluated in NTP-like two-generational studies), but they appeared to have no changes in fertility or litter size. It was noted that F2 litters in the GD 1719 and GD 1319 ATR-exposure groups were significantly reduced in body weight at both PND 4 and PND 11.
The mammary glands of these F2 offspring were also smaller and less developed than the other groups, and this was found to be due to reduced body weight. These data suggest that late-gestational ATR exposure has an indirect adverse effect on body weight of the next generation. The differences in results of the two studies mentioned above may be due to inconsistencies in time of breeding or differences in dose. We observed delayed MG development in the siblings of the females bred on PND 68. It is possible that we would not have seen any F2 effects if the females had been bred at a later time, such as at 90120 days, as is typical in two-generation studies. We have no proof that this effect is permanent, just long-lasting.
In conclusion, MG developmental delays observed in all groups of ATR-exposed pups suggest that GD 1719 is a sensitive window for fetal mammary gland development. While traditional endpoints were measured (body weight, puberty, and serum hormone concentrations), they were not associated with MG development effects in LE rats. Vorderstrasse et al. (2004) recently reported that mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin during pregnancy had trouble sustaining their young, resulting in pup death shortly after birth. Dioxin decreased branching, lobulo-alveolar development, and gland weight of treated dams when compared to controls. Fenton et al. (2002)
demonstrated that acute exposure to dioxin on GD 15 in LE rats led to persistent delays in female offspring MG development. The MG development observed in dioxin-exposed offspring is similar to what we observed in the present study. Given this similarity, it would be interesting to determine if ATR has an adverse effect on MG differentiation of the exposed dam. Studies to determine if ATR impairs maternal MG development during pregnancy and if ATR has a direct effect on MG development in the fetus would certainly shed light on the mechanism by which ATR causes these early and fairly persistent effects on MG of rats.
![]() |
DISCLAIMER |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
NOTES |
---|
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Blanck, H. M., Marcus, M., Tolbert, P. E., Rubin, C., Henderson, A. K., Hertzberg, V. S., Zhang, R. H., and Cameron, L. (2000). Age at menarche and Tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl. Epidemiology 11, 641647.[CrossRef][ISI][Medline]
Borellini, F., and Oka, T. (1998). Growth control and differentiation in mammary epithelial cells. Environ. Health Perspect. 80, 8589.
Charles River Laboratories. (1996). Historical Control Date (19921994) for Developmental and Reproductive Toxicity Studies using the Crl:CD©(SD)BR Rat. Table 2: Cesarean-Section Data (accessed May 24, 2005): <http://www.criver.com/techdocs/toxdata/hctab02.html>.
Chumlea, W. C., Schubert, C. M., Roche, A. F., Kulin, H. E., Lee, P. A., Himes, J. H., and Sun, S. S. (2003). Age at menarche and racial comparisons in US girls. Pediatrics 111, 110113.
Daniel, C. W., and Silberstein, G. B. (1987). Postnatal development of the rodent mammary gland. In The Mammary Gland (M. Neville and C. Daniel, Eds.), pp. 336, Plenum Press, New York.
Fenton, S. E., Hamm, J. T., Birnbaum, L. S., and Youngblood, G. L. (2002). Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Sci. 67, 6374.
Foster, W. G., Younglai, E. V., Boutross-Tadross, O., Hughes, C. L., and Wade, M. G. (2004). Mammary gland morphology in Sprague-Dawley rats following treatment with an organochlorine mixture in utero and neonatal genistein. Toxicol. Sci. 77, 91100.
Gianessi, L. P. (1998). Benefits of triazine herbicides. In Triazine Herbicides Risk Assessment, ACS Symposium Series (L.G. Ballantine, J. E. McFarland, and D. S. Hackett, Eds.), pp. 18, American Chemical Society, Washington, D.C.
Herman-Giddens, M. E., Slora, E. J., Wasserman, R. C., Bourdony, C. J., Bhapkar, M. V., Koch, G. G., and Hasemeier, C. M. (1997). Secondary sexual characteristics and menses in young girls seen in office practice: A study from the pediatric research in office settings network. Pediatrics 99, 505512.
Den Hond, E. D., Roels, H. A., Hoppenbrouwers, K., Nawrot, T., Thijs, L., Vandermeulen, C., Winneke, G., Vanderschueren, D., and Staessen, J. A. (2002). Sexual maturation in relation to polychlorinated aromatic hydrocarbons: Sharpe and Skakkebaek's hypothesis revisited. Environ. Health Perspect. 110, 771776.[ISI][Medline]
Hovey, R. C., Trott, J. F., and Vonderhaar, B. K. (2002). Establishing a framework for the functional mammary gland: From endocrinology to morphology. J. Mammary Gland Biol. Neoplasia 7, 1738.[CrossRef][ISI][Medline]
Imagawa, W., Bandyopadhyay, G. K., and Nandi, S. (1990). Regulation of mammary epithelial cell growth in mice and rats. Endocr. Rev. 11, 494523.[ISI][Medline]
Knight, C. H., and Sorensen, A. (2001). Windows in early mammary development: Critical or not? Reproduction 122, 337345.
Laws, S. C., Ferrell, J. M., Stoker, T. E., Schmid, J., and Cooper, R. L. (2000). The effects of atrazine on female Wistar rats: An evaluation of the protocol for assessing pubertal development and thyroid function. Toxicol. Sci. 58, 366367.
Mainiero, J., Youreneff, M., Giknis, M. L. A., and Yau, E. T. (1987). Two-generational reproduction study in rats: Atrazine technical laboratory study no. 852063. Unpublished study prepared by Ciba-Geigy Corp. 1395 p. MRID 40431303. Memorandum: Revised Human Health Risk Assessment: Atrazine. Toxicology Disciplinary Chapter for the Reregistration Eligibility Decision Document. (Revised April, 2002.) Office of Pesticide Programs. U.S. Environmental Protection Agency .
Markey, C. M., Luque, E. H., Munoz de Toro, M., Sonnenschein, C., and Soto, A. M. (2001). In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol. Reprod. 65, 12151223.
Rayner, J. L., Wood, C., and Fenton, S. E. (2004). Exposure parameters necessary for delayed puberty and mammary gland development in Long-Evans rats exposed in utero to atrazine. Toxicol. Appl. Pharmacol. 195, 2334.[CrossRef][ISI][Medline]
Stoker, T. E., Robinette, C. L., and Cooper, R. L. (1999). Maternal exposure to atrazine during lactation suppresses suckling-induced prolactin release and results in prostatitis in the adult offspring. Toxicol. Sci. 52, 6879.[Abstract]
Sun, S. S., Schbert, C. M., Chumlea, W. C., Roche, A. F., Kulin, H. E., Lee, P. A., Himes, J. H., and Ryan A. S. (2002). National estimates of the timing of sexual maturation and racial differences among US children. Pediatrics 110, 911919.
Vorderstrasse, B. A., Fenton, S. E., Bohn, A. A., Cundiff, J. A., and Lawrence, B. P. (2004). A novel effect of dioxin: Exposure during pregnancy severely impairs mammary gland differentiation. Toxicol. Sci. 78, 248257.
|